AHA 2021: Late-breaking Science Video Collection

Published: 12 November 2021

Views:
3584
Likes:
7

Views:
3584
Likes:
7
Share:

Now Playing
Part 3 | Session 10 of 11
EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic HF patients
Christiane Angermann

Up Next
11m 55s

Part 3 | Session 11 SPIRIT-HCM: Quality of Life After SM in Obstructive Patients With HCM

16m 38s

Part 1 | Session 1 AHA 2021 Late-breaker Discussion: The EMPULSE Trial Harriette Van Spall, Adriaan A Voors

16m 2s

Part 1 | Session 2 AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial John Spertus, Harriette Van Spall

12m 12s

Part 1 | Session 3 AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study Alexander J Blood, Harriette Van Spall

9m 51s

Part 2 View from the Thoraxcenter – What's Hot at AHA 2021 Nicolas M Van Mieghem, Joost Daemen

5m 28s

Part 3 | Session 1 Population Strategies for the Management of Hypertension Anushka Patel

5m 41s

Part 3 | Session 2 ROSE: CETPi Lowers LDL-C in Patients Taking High Intensity Statins Stephen Nicholls

7m 58s

Part 3 | Session 3 AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous Thromboembolism Jeffrey Weitz

6m 56s

Part 3 | Session 4 EAST-AFNET 4: Early Rhythm Control Was Consistent in AF Patterns Andreas Goette

6m 35s

Part 3 | Session 5 EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFp Javed Butler

10m 20s

Part 3 | Session 6 AHA 2021: Evaluating the Benefit of Concomitant TV Repair During Mitral Valve Surgery James Gammie

4m 26s

Part 3 | Session 7 SGLT2 is Associated with Reduction in Atrial-Arrythmic Events Ilan Goldenberg

8m 26s

Part 3 | Session 8 SMART-CRT: Effects of AV Optimization on CRT Outcomes Michael R Gold

10m 10s

Part 3 | Session 9 AVATAR: Aortic Valve Replacement Vs Watchful Waiting in Asymptomatic Severe AS Marko Banovic

Average (ratings)

No ratings

Your rating

Overview

Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen provide a concise and insightful preview of the late-breaking science presented at AHA Scientific Sessions 2021.

For a deep-dive, watch Dr Harriette Van Spall's Late-breaking Discussion series on highly expected trials with principal investigators.

Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

Late-breaker Discussion Series

Host, Dr Harriette Van Spall interviews the late-breaker presenters of AHA Scientific Sessions 2021.

3 sessions
AHA 2021 Late-breaker Discussion: The EMPULSE Trial	Watch now
AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial	Watch now
AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study	Watch now

Part 2

View from the Thoraxcenter: Preview of the Late-Breaking Trials

1 session
View from the Thoraxcenter – What's Hot at AHA 2021	Watch now

Part 3

Expert Interviews

Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.

11 sessions
Population Strategies for the Management of Hypertension	Watch now
ROSE: CETPi Lowers LDL-C in Patients Taking High Intensity Statins	Watch now
AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous Thromboembolism	Watch now
EAST-AFNET 4: Early Rhythm Control Was Consistent in AF Patterns	Watch now
EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFp	Watch now
AHA 2021: Evaluating the Benefit of Concomitant TV Repair During Mitral Valve Surgery	Watch now
SGLT2 is Associated with Reduction in Atrial-Arrythmic Events	Watch now
SMART-CRT: Effects of AV Optimization on CRT Outcomes	Watch now
AVATAR: Aortic Valve Replacement Vs Watchful Waiting in Asymptomatic Severe AS	Watch now
EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic HF patients	Watch now
SPIRIT-HCM: Quality of Life After SM in Obstructive Patients With HCM	Watch now

Faculty Biographies

Christiane Angermann

Professor

Prof Christiane E. Angermann is trained in Medicine/Cardiology in Munich. At the Munich Univ. Hospital, she established a Multidisciplinary Program for Advanced Heart Failure (HF)/HTX. In 2001, she became Professor of Medicine/Cardiology at Würzburg University, heading the Cardiology Division, Department of Medicine II. She is one of the 5 founders of the Comprehensive Heart Failure Center Würzburg (CHFC), became CHFC Director of Clinical Research in 2010, and is currently Senior CHFC Professor of Clinical Research in Cardiology/HF.

Her main interests are healthcare research, eHealth and telemedicine, multi-morbidity, heart-mind-body interactions and prevention of HF.

Prof Angermann is/was an EC/SC member and/or National Leader of multiple clinical trials, (e.g., REPORT-HF, MEMS-HF, PASSPORT-HF, EMPULSE), and acts as reviewer, Ed. Board member or Editor-in-Chief (Current Heart Failure Reports) for many journals.

View full profile